Please Wait
Applying Filters...
menu
    • menu
    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-08-25

    Virtual Booth

    An Enquiry

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Sovateltide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 302,840Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pharmazz Begins Phase 3 Trial of Sovateltide for Ischemic Stroke
    Pharmazz Begins Phase 3 Trial of Sovateltide for Ischemic Stroke

    29 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/29/3123098/0/en/Pharmazz-Inc-Announces-Enrollment-of-First-Patient-in-Phase-3-Clinical-Trial-of-Sovateltide-for-Treating-Patients-with-Cerebral-Ischemic-Stroke.html

    GLOBENEWSWIRE
    29 Jul 2025
    Share Share
    Pharmazz Inc. gets $25M investment from Sun Pharma
    Pharmazz Inc. gets $25M investment from Sun Pharma

    11 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/11/3097415/0/en/Pharmazz-Inc-Secures-25-Million-Strategic-Equity-Investment-from-Sun-Pharmaceutical-Industries-Ltd.html

    GLOBENEWSWIRE
    11 Jun 2025
    Share Share
    Sun Pharma To Invest Up To $15M In Pharmazz
    Sun Pharma To Invest Up To $15M In Pharmazz

    21 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/21/2933391/0/en/Pharmazz-Inc-and-Sun-Pharma-entered-into-an-agreement-under-which-Sun-Pharma-will-invest-up-to-15-Million-in-Pharmazz-Inc.html

    GLOBENEWSWIRE
    21 Aug 2024
    Share Share
    A Special Protocol Assessment Agreement Reached with FDA for Ph 3 of Sovateltide
    A Special Protocol Assessment Agreement Reached with FDA for Ph 3 of Sovateltide

    02 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/02/2752648/0/en/A-Special-Protocol-Assessment-Agreement-Reached-with-the-U-S-Food-and-Drug-Administration-for-Phase-3-clinical-trial-of-Sovateltide-for-the-treatment-of-acute-cerebral-ischemic-str.html

    GLOBENEWSWIRE
    02 Oct 2023
    Share Share
    Pharmazz Announces US FDA Clearance for a PhIII Clinical Trial of Sovateltide
    Pharmazz Announces US FDA Clearance for a PhIII Clinical Trial of Sovateltide

    13 Feb 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/pharmazz-inc-announces-us-fda-clearance-for-a-phase-iii-clinical-trial-of-sovateltide-pmz-1620-in-acute-cerebral-ischemic-stroke-patients-301744465.html

    PR NEWSWIRE
    13 Feb 2023
    Share Share
    Clinical PIII Trial Results Demonstrating Sovateltide's Efficacy
    Clinical PIII Trial Results Demonstrating Sovateltide's Efficacy

    10 Feb 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/clinical-phase-iii-trial-results-demonstrating-sovateltides-efficacy-to-treat-acute-cerebral-ischemic-stroke-presented-at-the-international-stroke-conference-2023-301741886.html

    PR NEWSWIRE
    10 Feb 2023
    Share Share